Multifactorial control and treatment intensity of type-2 diabetes in primary care settings in Catalonia
- PMID: 20350315
- PMCID: PMC2858123
- DOI: 10.1186/1475-2840-9-14
Multifactorial control and treatment intensity of type-2 diabetes in primary care settings in Catalonia
Abstract
Background: Many studies on diabetes have demonstrated that an intensive control of glycaemia and the main associated risk factors (hypertension, dislipidaemia, obesity and smoking) reduce cardiovascular morbi-mortality. Different scientific societies have proposed a multifactorial approach to type 2 diabetes.The objective of this study was to identify the degree of control of glycosylated haemoglobin (HbA1c) and of cardiovascular risk factors in type 2 diabetic patients, using the GedapS 2004 guidelines, and to analyse the type and intensity of drug treatment.
Methods: This cross-sectional, multicentre, epidemiological study was conducted in a primary care setting in Vallès Occidental South, Catalonia. Data were collected of 393 patients aged 18 and above who were diagnosed with diabetes mellitus type 2. Biodemographic and clinical data, cardiovascular risk factors, associated cardiovascular disease, and treatment were assessed. Descriptive and multivariable analysis with logistic regression was realized.
Results: A total of 392 patients with a mean age of 66.8 years (SD = 10.6) (45.4% male patients) were analyzed. The duration of diabetes was 8.4 years (SD = 7.6). The degree of multifactorial control of risk factors was only 2.6%, although in more than 50% individual cardiovascular risk factor was controlled, except for LDL cholesterol (40.6%) and systolic blood pressure (29.6%). Furthermore, only 13.0% of subjects had an optimal BMI, 27.5% an optimal waist circumference. Treatment for diabetes was prescribed in 82.7% of patients, for hypertension 70.7%, for dyslipidaemia 47.2% and 40.1% were taking antiplatelets.
Conclusion: Over 50% of type 2 diabetic patients presented optimal control of the majority of individual cardiovascular risk factors, although the degree of multifactorial control of diabetes was insufficient (2.6%) and should be improved. Drug treatment can be intensified using a larger number of combinations, particularly in patients with target organ damage and associated clinical cardiovascular disease.
Figures

Similar articles
-
Effect of Multifactorial Treatment Targets and Relative Importance of Hemoglobin A1c, Blood Pressure, and Low-Density Lipoprotein-Cholesterol on Cardiovascular Diseases in Chinese Primary Care Patients With Type 2 Diabetes Mellitus: A Population-Based Retrospective Cohort Study.J Am Heart Assoc. 2017 Aug 17;6(8):e006400. doi: 10.1161/JAHA.117.006400. J Am Heart Assoc. 2017. PMID: 28862945 Free PMC article.
-
Glycaemic, blood pressure and lipid goal attainment and chronic kidney disease stage of type 2 diabetic patients treated in primary care practices.Swiss Med Wkly. 2017 Jul 6;147:w14459. doi: 10.4414/smw.2017.14459. eCollection 2017. Swiss Med Wkly. 2017. PMID: 28695552
-
Impact of a multifactorial treatment programme on clinical outcomes and cardiovascular risk estimates: a retrospective cohort study from a specialised diabetes centre in Denmark.BMJ Open. 2018 Mar 17;8(3):e019214. doi: 10.1136/bmjopen-2017-019214. BMJ Open. 2018. PMID: 29550776 Free PMC article.
-
Management of cardiovascular risk in patients with type 2 diabetes mellitus as a component of the cardiometabolic syndrome.J Cardiometab Syndr. 2006 Spring;1(2):133-40. doi: 10.1111/j.1559-4564.2006.05487.x. J Cardiometab Syndr. 2006. PMID: 17679832 Review.
-
[Glycemic targets and cardiovascular morbi-mortality].Presse Med. 2013 May;42(5):855-60. doi: 10.1016/j.lpm.2012.02.052. Epub 2012 Dec 31. Presse Med. 2013. PMID: 23286961 Review. French.
Cited by
-
16S gut community of the Cameron County Hispanic Cohort.Microbiome. 2015 Mar 6;3:7. doi: 10.1186/s40168-015-0072-y. eCollection 2015. Microbiome. 2015. PMID: 25763184 Free PMC article.
-
A descriptive study of health status and health related quality of life in selected outpatients with type 2 diabetes, pathological body mass index and cardiovascular risk in Spain.Diabetol Metab Syndr. 2014 Dec 6;6:135. doi: 10.1186/1758-5996-6-135. eCollection 2014. Diabetol Metab Syndr. 2014. PMID: 25960775 Free PMC article.
-
Characteristics of poorly controlled Type 2 diabetes patients in Swiss primary care.Cardiovasc Diabetol. 2012 Jun 15;11:70. doi: 10.1186/1475-2840-11-70. Cardiovasc Diabetol. 2012. PMID: 22704274 Free PMC article. Clinical Trial.
-
Screening for Potential Novel Probiotics With Dipeptidyl Peptidase IV-Inhibiting Activity for Type 2 Diabetes Attenuation in vitro and in vivo.Front Microbiol. 2020 Jan 10;10:2855. doi: 10.3389/fmicb.2019.02855. eCollection 2019. Front Microbiol. 2020. PMID: 31998245 Free PMC article.
-
Diagnosed diabetes and optimal disease control of prisoners in Catalonia.Rev Esp Sanid Penit. 2020 Jan-Apr;22(1):16-22. doi: 10.18176/resp.0003. Epub 2020 Apr 27. Rev Esp Sanid Penit. 2020. PMID: 32406477 Free PMC article.
References
-
- Godoy A. Epidemiology of diabetes and its non-coronary complications. Rev Esp Cardiol. 2002;55:657–70. - PubMed
-
- World Health Organization. Diabetes programme. Facts and figures. WHO European Region. 2000. http://www.who.int/diabetes/facts/world_figures/en/index4.html
-
- Instituto Nacional de Estadística. Defunciones según la causa de muerte 2004. Resultados básicos. Estadísticas del movimiento natural de la población. http://www.ine.es
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical